Mannose-binding lectin in pre-menopausal women with recurrent urinary tract infections

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1394-1398

  Colodner, R ^a   Nitzan, O ^b   Chazan, B ^b,c   Edelstein, H ^b   Raz, R ^b,c  

^a Laboratory Medicine Department   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Lectin; Mannose binding; Pre menopausal; Recurrent; UTI

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECURRENT INFECTION; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT INFECTION;

CANDIDA; STAPHYLOCOCCUS AUREUS;

EID: 77956123007     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03107.x     Document Type: Article

References (30)

1. Super MS, Thiel J, Lu RJ. Association of low levels of mannan-binding protein protein with a common defect of opsonization. Lancet 1989, 2:1236-1239.
2. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998, 199:327-339.
3. Neth O, Jack DL, Dodds AW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement disposition. Infect Immun 2000, 68:688-693.
4. Holmskov U, Thiel S, Jensenius JC. Collectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2002, 21:547-578.
5. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003, 37:1496-1505.
6. Madsen HO, Satz ML, Hogh B. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998, 161:3169-3175.
7. Super M, Gillies SD, Foley S. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 1992, 2:50-55.
8. Kars M, van Dijk H, Salimans MM. Association of forunculosis and familial deficiency of mannose-binding lectin. Eur J Clin Invest 2005, 35:531-534.
9. Eisen DP, Dean MM, Boermeester MA. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008, 47:510-516.
10. Roy S, Knox K, Segal S. MBL genotype and risk of invasive pneumoccocal disease. Lancet 2002, 359:1569-1573.
11. Ip WK, Lau YL. Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J Infect Dis 2004, 190:632-640.
12. Hooton TM. The epidemiology of urinary tract infection and the concept of significant bacteriuria. Infection 1990, 18(suppl 2):S40-S43.
13. Raz R. Postmenopausal women with recurrent UTI. Int J Antimicrob Agents 2001, 17:269-271.
14. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001, 17:259-268.
15. Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am 1997, 11:719-733.
16. Foxman B, Somsel P, Tallman P. Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol 2001, 54:710-718.
17. Shang SQ, Chen GX, Shen J. The binding to common bacteria in infectious diseases of children. J Zhejiang Univ Sci B 2005, 6:53-56.
18. Shiratsuchi A, Watanabe I, Ju JS. Bridging effect of recombinant human mannose-binding lectin in macrophage phagocytosis of Escherichia coli. Immunology 2008, 124:575-583.
19. Smithson A, Muñoz A, Suarez B. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol 2007, 14:256-261.
20. Li K, Sacks SH, Sheerin NS. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli. Mol Immunol 2008, 45:954-962.
21. Neth O, Jack DL, Johnson M. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 2002, 169:4430-4436.
22. Madsen HO, Garred P, Thiel S. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995, 155:3013-3020.
23. Capparelli R, Iannaccone M, Palumbo D. Role played by human mannose-binding lectin polymorphisms in pulmonary tuberculosis. J Infect Dis 2009, 199:666-672.
24. Kirkpatrick BD, Huston CD, Wagner D. Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis 2006, 43:289-294.
25. Donders GG, Babula O, Bellen G. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginitis candidiasis. BJOG 2008, 115:1225-1231.
26. Peterslund NA, Koch K, Jensenius JC. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001, 358:637-638.
27. Worthley DL, Mullighan CG, Dean MM. Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol 2007, 19:147-152.
28. Parrella P, Seripa D, Matera MG. Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection. Eur J Epidemiol 2007, 22:159-162.
29. Bultink IE, Hamann D, Seelen MA. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther 2006, 8:R183.
30. Dahl M, Tybjaerg-Hansen A, Schnohr P. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004, 199:1391-1399.